Colin Kelley

Colin Kelley currently serves as the Sr. Operating Partner at Merida Capital Holdings, where the investment focus centers on the normalization of cannabis across various markets. With extensive experience in the cannabis industry, Colin has held multiple leadership positions, including Board Observer at 3Fifteen Primo Cannabis, Board Member at Brytemap and Dharma Pharmaceuticals, and Member of the Board of Directors at Inlight and Cannabis Dispensary. Previous roles include Director of Integration at National Cardiovascular Partners and Vice President Development at Haze.Delivery. Colin's foundational experience also includes serving as CFO and COO at LeafLine Labs, a major player in Minnesota’s medical cannabis program. Colin holds a BSBA in Finance & Management from Bryant University.